Rheumatology International

, Volume 31, Issue 2, pp 221–226 | Cite as

Functional capacity in rheumatoid arthritis patients: comparison between Spanish and Brazilian sample

  • Maiza Ritomy Ide
  • Miguel A. Gonzalez-Gay
  • Kelly Cristina Yano
  • Marcelo Jun Imai
  • Mario Chueire de AndradeJr.
  • Javier Llorca
Original Article

Abstract

The main objective of this study is to compare Spanish and Brazilian self-reported health-related functional capacity in patients with rheumatoid arthritis (RA). 197 patients diagnosed with RA were studied in Spain (n = 127) and Brazil (n = 70). Pain (Visual analog scale) and functional capacity (Health Assessment Questionnaire/HAQ) were assessed. Patients were questioned about regular exercise practice. Comparisons between groups were performed with Chi-square tests and Student t test. Pearson’s correlation coefficient and linear regression models were used to analyze the associations. Brazilian patients were younger (p = 0.013), had worse levels of pain (p = 0.001) and a trend to experience worse functional capacity (p = 0.057) than Spanish ones. Spanish RA patients had higher body mass index (BMI) (p = 0.019) and longer disease duration (p = 0.001). Also, a higher percentage of subjects with RA from the Spanish cohort had been elected to take early retirement when compared with Brazilian patients (p = 0.010). Spanish RA patients had received more drugs than Brazilians (oral corticosteroids p = 0.010, Leflunomide p = 0.023, Methotrexate p = 0.072, non-steroidal anti-inflammatory drugs p = 0.064, biologic therapies p = 0.001). The functional capacity (HAQ) was correlated with age (p = 0.001), disease duration (p = 0.001), age at diagnosis (p = 0.001), pain (p = 0.001) and BMI (p = 0.001) in Spanish patients. In Brazilian, these correlations were only found with disease duration (p = 0.004) and pain (p = 0.001). In conclusion, our data suggest a better management of RA in Spanish when compared with Brazilians. Even with less pain and functional capacity, they receive more drug treatment and a higher percentage of them are retired early.

Keywords

Functional capacity Rheumatoid arthritis Brazil Spain 

Notes

Acknowledgments

The authors thank the staff and patients of Hospital Xeral-Calde, Lugo (Spain). We especially thank to Dr. Amalia Sanchez-Andrade, Dr. José Alberto Miranda Filloy, Dr. Tomás Ramón Vázquez Rodríguez members of the Rheumatology Division and Mrs. Susana Escandón nurse from the Rheumatology Division of Hospital Xeral-Calde, Lugo (Spain) for the valuable help in the recruitment of the patients. We also thank to Brazilian National Research and Development Council (CNPq) for supporting Dr. Ide fellowship.

References

  1. 1.
    Akbulut Aktekin L, Eser F, Malhan S, Oksüz E, Keskin D, Bodur H (2009) A comparison of four different HRQoL generic questionnaire in five different patient groups. Rheumatol Int (epub ahead of print)Google Scholar
  2. 2.
    Laas K, Roine R, Räsänen P, Sintonen H, Leirisalo-Repo M, HUS QoL Study Group (2009) Health-related quality of life in patients with common rheumatic diseases referred to a university clinic. Rheumatol Int 29:267–273CrossRefPubMedGoogle Scholar
  3. 3.
    Tander B, Cengiz K, Alayli G, Ilhanli I, Canbaz S, Canturk F (2008) A comparative evaluation of health related quality of life and depression in patients with fibromyalgia syndrome and rheumatoid arthritis. Rheumatol Int 28:859–865CrossRefPubMedGoogle Scholar
  4. 4.
    Louzada-Junior P, Souza BDB, Toledo RA, Ciconelli RM (2007) Análise descritiva das características demográficas e clínicas de pacientes com artrite reumatóide no Estado de São Paulo-Brasil. Rev Bras Reumatol 47:84–90CrossRefGoogle Scholar
  5. 5.
    Howe HS, Zhao L, Song YW, Springer L, Edmonds J, Gu J et al (2007) Seronegative spondyloarthropathy-studies from the Asia Pacific region. Ann Acad Med Singap 36:135–141PubMedGoogle Scholar
  6. 6.
    Celia D, Nowinsky CJ (2002) Measuring quality of life in chronic illness: the functional assessment of chronic illness therapy measurement system. Arch Phys Med Rehabil 83:10–17CrossRefGoogle Scholar
  7. 7.
    Whalley D, McKenna SP, de Jong Z, van der Heijde D (1997) Quality of life in rheumatoid arthritis. Br J Rheumatol 36:884–888CrossRefPubMedGoogle Scholar
  8. 8.
    Mason JH, Weener JL, Gertman PM, Meenan RF (1983) Health status in chronic disease: a comparative study of rheumatoid arthritis. J Rheumatol 10:763–768PubMedGoogle Scholar
  9. 9.
    Laas K, Peltomaa R, Puolakka K, Kautiainen H, Leirisalo-Repo M (2009) Early improvement of health-related quality of life during treatment with etanercept and adalimumab in patients with rheumatoid arthritis in routine practice. Clin Exp Rheumatol 27:315–320PubMedGoogle Scholar
  10. 10.
    Singh JA, Strand V (2009) Spondyloarthritis is associated with poor function and physical health-related quality of life. J Rheumatol 36:1012–1020CrossRefPubMedGoogle Scholar
  11. 11.
    Torigoe DY, Laurindo IMM (2006) Artrite reumatóide e doenças cardiovasculares. Rev Bras Reumatol 46:60–66CrossRefGoogle Scholar
  12. 12.
    Carvalho JAM, Garcia RA (2003) O envelhecimento da população brasileira: um enfoque demográfico. Cad Saude Publica 19:725–733PubMedGoogle Scholar
  13. 13.
    Veras R (2009) Population aging today: demands, challenges and innovations. Rev Saude Publica 43:548–554PubMedGoogle Scholar
  14. 14.
    DC C (1994) Centers for Diseases Control and Prevention. Arthritis prevalence and activity limitations, United States, 1990. MMWR Morb Mortal Wkly Rep 43:433–438Google Scholar
  15. 15.
    Senna ER, De Barros AL, Silva EO, Costa IF, Pereira LV, Ciconelli RM et al (2004) Prevalence of rheumatic diseases in Brazil: a study using the COPCORD approach. J Rheumatol 31:594–597PubMedGoogle Scholar
  16. 16.
    Chermont GC, Kowalski SC, Ciconelli RM, Ferraz MB (2008) Resource utilization and the cost of rheumatoid arthritis in Brazil. Clin Exp Rheumatol 26:24–31PubMedGoogle Scholar
  17. 17.
    Eurostat (2007) Europe in figures. Eurostat Yearbook 2006–2007. Naciones UnidasGoogle Scholar
  18. 18.
    Rubio-Terrés C, Ordovás Baines JP, Pla Poblador R, Martínez Nieto C, Sánchez Garre MJ, Rosado Souvirón MA et al (2007) Grupo de Investigadores del Estudio PRAXIS. Use and cost of biological disease-modifying anti-rheumatic drugs in Spain (PRAXIS study). Farm Hosp 31:78–92CrossRefPubMedGoogle Scholar
  19. 19.
    Carmona L, Villaverde V, Hernández-García C, Ballina J, Gabriel R, Laffon A (2002) EPISER Study Group. The prevalence of rheumatoid arthritis in the general population of Spain. Rheumatology (Oxford) 41:88–95CrossRefGoogle Scholar
  20. 20.
    Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS et al (1998) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324CrossRefGoogle Scholar
  21. 21.
    Gonzalez-Gay MA, Gonzalez-Juanatey C, Lopez-Diaz MJ, Piñeiro A, Garcia-Porrua C, Miranda-Filloy JA, Ollier WE, Martin J, Llorca J (2007) HLA-DRB1 and persistent chronic inflammation contribute to cardiovascular events and cardiovascular mortality in patients with rheumatoid arthritis. Arthritis Rheum 57:125–132CrossRefPubMedGoogle Scholar
  22. 22.
    Prevoo ML, van’t Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL (1995) Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38:44–48CrossRefPubMedGoogle Scholar
  23. 23.
    Haskell WL, Lee IM, Pate RR, Powell KE, Blair SN, Franklin BA et al (2007) Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. Med Sci Sports Exerc 39:1423–1434CrossRefPubMedGoogle Scholar
  24. 24.
    Ferraz MB, Oliveira IM, Araujo PM, Atra E, Tugwell P (1990) Crosscultural reliability of the physical ability dimension of the health assessment questionnaire. J Rheumatol 17:813–817PubMedGoogle Scholar
  25. 25.
    Chorus AM, Miedema HS, Boonen A, Van Der Linden S (2003) Quality of life and work in patients with rheumatoid arthritis and ankylosing spondylitis of working age. Ann Rheum Dis 62:1178–1184CrossRefPubMedGoogle Scholar
  26. 26.
    Gonzalez-Gay MA, Garcia-Unzueta MT, Berja A, Vazquez-Rodriguez TR, Miranda-Filloy JA, Gonzalez-Juanatey C et al (2009) Short-term effect of anti-TNF-alpha therapy on nitric oxide production in patients with severe rheumatoid arthritis. Clin Exp Rheumatol 27:452–458PubMedGoogle Scholar
  27. 27.
    Gonzalez-Juanatey C, Llorca J, Vazquez-Rodriguez TR, Diaz-Varela N, Garcia-Quiroga H, Gonzalez-Gay MA (2008) Short-term improvement of endothelial function in rituximab-treated rheumatoid arthritis patients refractory to tumor necrosis factor alpha blocker therapy. Arthritis Rheum 59:1821–1824CrossRefPubMedGoogle Scholar
  28. 28.
    Gonzalez-Gay MA, Garcia-Unzueta MT, Berja A, Vazquez-Rodriguez TR, Gonzalez-Juanatey C, de Matias JM et al (2008) Anti-tumour necrosis factor alpha therapy modulates ghrelin in patients with severe rheumatoid arthritis. Ann Rheum Dis 67:1644–1646CrossRefPubMedGoogle Scholar
  29. 29.
    Gibbons LJ, Hyrich KL (2009) Biologic therapy for rheumatoid arthritis: clinical efficacy and predictors of response. BioDrugs 23:111–124CrossRefPubMedGoogle Scholar
  30. 30.
    Hyrich KL, Watson KD, Silman AJ, Symmons DP (2006) Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register. Rheumatology (Oxford) 45:1558–1565CrossRefGoogle Scholar
  31. 31.
    Monteiro RDC, Zanini AC (2008) Análise de custo do tratamento medicamentoso da artrite reumatóide. Rev Bras Cienc Farm 44:25–33Google Scholar
  32. 32.
    Gabriel SE, Colyle D, Moreland LW (2001) A clinical and economic review of disease-modifying antirheumatic drugs. Pharmacoeconomics 19:715–728CrossRefPubMedGoogle Scholar
  33. 33.
    McDougall JJ (2006) Arthritis and pain: neurogenic origin of joint pain. Arthritis Res Ther 8:220–230CrossRefPubMedGoogle Scholar
  34. 34.
    Vlaar AP, ten Klooster PM, Taal E, Gheith RE, El-Garf AK, Rasker JJ et al (2007) A cross-cultural study of pain intensity in Egyptian and Dutch women with rheumatoid arthritis. J Pain 8:730–736CrossRefPubMedGoogle Scholar
  35. 35.
    Phillips DM (2000) Pain management standards are unveiled. JAMA 284:428–429CrossRefPubMedGoogle Scholar
  36. 36.
    Fitzcharles MA, DaCosta D, Ware MA, Shir Y (2009) Patient barriers to pain management may contribute to poor pain control in rheumatoid arthritis. J Pain 10:300–305CrossRefPubMedGoogle Scholar
  37. 37.
    Kojima M, Kojima T, Suzuki S, Oguchi T, Oba M, Tsuchiya H et al (2009) Depression, inflammation, and pain in patients with rheumatoid arthritis. Arthritis Rheum 61:1018–1024CrossRefPubMedGoogle Scholar
  38. 38.
    Zautra AJ, Parrish BP, Van Puymbroeck CM, Tennen H, Davis MC, Reich JW, Irwin M (2007) Depression history, stress, and pain in rheumatoid arthritis patients. J Behav Med 30:187–197CrossRefPubMedGoogle Scholar
  39. 39.
    Sokka T, Häkkinen A (2008) Poor physical fitness and performance as predictors of mortality in normal populations and patients with rheumatic and other diseases. Clin Exp Rheumatol 26:S14–S20PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2009

Authors and Affiliations

  • Maiza Ritomy Ide
    • 1
    • 4
  • Miguel A. Gonzalez-Gay
    • 2
  • Kelly Cristina Yano
    • 1
  • Marcelo Jun Imai
    • 1
  • Mario Chueire de AndradeJr.
    • 1
  • Javier Llorca
    • 3
  1. 1.Universidade Estadual do Oeste do ParanáCascavelBrazil
  2. 2.Hospital Xeral-CaldeLugoSpain
  3. 3.Epidemiology and Computational Biology, School of Medicine and CIBER Epidemiología y Salud PúblicaUniversity of CantabriaSantanderSpain
  4. 4.São José dos CamposBrazil

Personalised recommendations